158 related articles for article (PubMed ID: 32057798)
1. Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q11.2 deletion syndrome.
Armando M; Ciampoli M; Padula MC; Amminger P; De Crescenzo F; Maeder J; Schneider M; Schaer M; Managò F; Eliez S; Papaleo F
Neuropharmacology; 2020 May; 168():107995. PubMed ID: 32057798
[TBL] [Abstract][Full Text] [Related]
2. Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial.
Armando M; De Crescenzo F; Vicari S; Digilio MC; Pontillo M; Papaleo F; Amminger GP
Early Interv Psychiatry; 2016 Oct; 10(5):390-6. PubMed ID: 25345540
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
[TBL] [Abstract][Full Text] [Related]
4. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.
Vorstman JA; Breetvelt EJ; Duijff SN; Eliez S; Schneider M; Jalbrzikowski M; Armando M; Vicari S; Shashi V; Hooper SR; Chow EW; Fung WL; Butcher NJ; Young DA; McDonald-McGinn DM; Vogels A; van Amelsvoort T; Gothelf D; Weinberger R; Weizman A; Klaassen PW; Koops S; Kates WR; Antshel KM; Simon TJ; Ousley OY; Swillen A; Gur RE; Bearden CE; Kahn RS; Bassett AS;
JAMA Psychiatry; 2015 Apr; 72(4):377-85. PubMed ID: 25715178
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal perspectives on the psychosis spectrum in 22q11.2 deletion syndrome.
Tang SX; Gur RE
Am J Med Genet A; 2018 Oct; 176(10):2192-2202. PubMed ID: 29048724
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis.
Radoeva PD; Fremont W; Antshel KM; Kates WR
Dev Psychopathol; 2017 Feb; 29(1):93-106. PubMed ID: 26864886
[TBL] [Abstract][Full Text] [Related]
7. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
[TBL] [Abstract][Full Text] [Related]
8. Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.
Antshel KM; Fremont W; Ramanathan S; Kates WR
Schizophr Bull; 2017 Jul; 43(4):833-842. PubMed ID: 27798222
[TBL] [Abstract][Full Text] [Related]
9. Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness.
Ching CRK; Gutman BA; Sun D; Villalon Reina J; Ragothaman A; Isaev D; Zavaliangos-Petropulu A; Lin A; Jonas RK; Kushan L; Pacheco-Hansen L; Vajdi A; Forsyth JK; Jalbrzikowski M; Bakker G; van Amelsvoort T; Antshel KM; Fremont W; Kates WR; Campbell LE; McCabe KL; Craig MC; Daly E; Gudbrandsen M; Murphy CM; Murphy DG; Murphy KC; Fiksinski A; Koops S; Vorstman J; Crowley TB; Emanuel BS; Gur RE; McDonald-McGinn DM; Roalf DR; Ruparel K; Schmitt JE; Zackai EH; Durdle CA; Goodrich-Hunsaker NJ; Simon TJ; Bassett AS; Butcher NJ; Chow EWC; Vila-Rodriguez F; Cunningham A; Doherty J; Linden DE; Moss H; Owen MJ; van den Bree M; Crossley NA; Repetto GM; Thompson PM; Bearden CE
Am J Psychiatry; 2020 Jul; 177(7):589-600. PubMed ID: 32046535
[TBL] [Abstract][Full Text] [Related]
10. Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.
Yi JJ; Tang SX; McDonald-McGinn DM; Calkins ME; Whinna DA; Souders MC; Zackai EH; Goldmuntz E; Gaynor JW; Gur RC; Emanuel BS; Gur RE
Am J Med Genet B Neuropsychiatr Genet; 2014 Mar; 165B(2):137-47. PubMed ID: 24265253
[TBL] [Abstract][Full Text] [Related]
11. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
Sun D; Ching CRK; Lin A; Forsyth JK; Kushan L; Vajdi A; Jalbrzikowski M; Hansen L; Villalon-Reina JE; Qu X; Jonas RK; van Amelsvoort T; Bakker G; Kates WR; Antshel KM; Fremont W; Campbell LE; McCabe KL; Daly E; Gudbrandsen M; Murphy CM; Murphy D; Craig M; Vorstman J; Fiksinski A; Koops S; Ruparel K; Roalf DR; Gur RE; Schmitt JE; Simon TJ; Goodrich-Hunsaker NJ; Durdle CA; Bassett AS; Chow EWC; Butcher NJ; Vila-Rodriguez F; Doherty J; Cunningham A; van den Bree MBM; Linden DEJ; Moss H; Owen MJ; Murphy KC; McDonald-McGinn DM; Emanuel B; van Erp TGM; Turner JA; Thompson PM; Bearden CE
Mol Psychiatry; 2020 Aug; 25(8):1822-1834. PubMed ID: 29895892
[TBL] [Abstract][Full Text] [Related]
12. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
[TBL] [Abstract][Full Text] [Related]
13. Cognitive phenotype and psychiatric disorder in 22q11.2 deletion syndrome: A review.
Biswas AB; Furniss F
Res Dev Disabil; 2016; 53-54():242-57. PubMed ID: 26942704
[TBL] [Abstract][Full Text] [Related]
14. Early language measures associated with later psychosis features in 22q11.2 deletion syndrome.
Solot CB; Moore TM; Crowley TB; Gerdes M; Moss E; McGinn DE; Emanuel BS; Zackai EH; Gallagher S; Calkins ME; Ruparel K; Gur RC; McDonald-McGinn DM; Gur RE
Am J Med Genet B Neuropsychiatr Genet; 2020 Sep; 183(6):392-400. PubMed ID: 32715620
[TBL] [Abstract][Full Text] [Related]
15. Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion.
Chun S; Du F; Westmoreland JJ; Han SB; Wang YD; Eddins D; Bayazitov IT; Devaraju P; Yu J; Mellado Lagarde MM; Anderson K; Zakharenko SS
Nat Med; 2017 Jan; 23(1):39-48. PubMed ID: 27892953
[TBL] [Abstract][Full Text] [Related]
16. Specific differences in temporal binding aspects of the attentional blink in Chromosome 22q11.2 Deletion Syndrome.
Kopec J; Russo N; Antshel KM; Fremont W; Kates WR
Cortex; 2018 Nov; 108():67-79. PubMed ID: 30130634
[TBL] [Abstract][Full Text] [Related]
17. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
Smesny S; Milleit B; Schaefer MR; Hesse J; Schlögelhofer M; Langbein K; Hipler UC; Berger M; Cotter DR; Sauer H; McGorry PD; Amminger GP
Schizophr Res; 2017 Oct; 188():110-117. PubMed ID: 28126360
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome.
Hooper SR; Curtiss K; Schoch K; Keshavan MS; Allen A; Shashi V
Res Dev Disabil; 2013 May; 34(5):1758-69. PubMed ID: 23506790
[TBL] [Abstract][Full Text] [Related]
19. Clinical and cognitive risk factors for psychotic symptoms in 22q11.2 deletion syndrome: a transversal and longitudinal approach.
Schneider M; Schaer M; Mutlu AK; Menghetti S; Glaser B; Debbané M; Eliez S
Eur Child Adolesc Psychiatry; 2014 Jun; 23(6):425-36. PubMed ID: 23999732
[TBL] [Abstract][Full Text] [Related]
20. Computer-vision analysis of craniofacial dysmorphology in 22q11.2 deletion syndrome and psychosis spectrum disorders.
Roalf DR; McDonald-McGinn DM; Jee J; Krall M; Crowley TB; Moberg PJ; Kohler C; Calkins ME; Crow AJD; Fleischer N; Gallagher RS; Gonzenbach V; Clark K; Gur RC; McClellan E; McGinn DE; Mordy A; Ruparel K; Turetsky BI; Shinohara RT; White L; Zackai E; Gur RE
J Neurodev Disord; 2024 Jun; 16(1):35. PubMed ID: 38918700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
